SCHEMBL4603073

SCHEMBL4603073

COc1cccc(-c2ccc(OC)c(C(=O)O)c2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.61
POLB P06746 1/20 0.61
DHODH Q02127 3/20 0.55
HSD17B1 P14061 1/20 0.54
ALDH1A1 P00352 3/20 0.53
HPGD P15428 2/20 0.53
CFD P00746 1/20 0.53
HDAC4 P56524 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
APAF1 O14727 1/20 0.50
RECQL P46063 1/20 0.50
CASP6 P55212 1/20 0.50
CACNA1B Q00975 1/20 0.50
APBA1 Q02410 1/20 0.50
MCL1 Q07820 1/20 0.50
CASP8 Q14790 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
LMNA P02545 1/20 0.50
GPR35 Q9HC97 1/20 0.50
HCAR2 Q8TDS4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4615367 0.87 RXRA (0.58) KDM4EPOLBDHODHHSD17B1ALDH1A1
SCHEMBL3933361 0.87 RXRA (0.57) KDM4EPOLBDHODHHPGDLMNA
SCHEMBL3996761 0.87 MCL1 (0.59) KDM4EALDH1A1HPGDCFDAPAF1
SCHEMBL2769498 0.87 CFD (0.67) KDM4EPOLBALDH1A1HPGDCFD
SCHEMBL3946016 0.86 KDM4E (0.53) KDM4EPOLBDHODHHSD17B1CFD
SCHEMBL3015373 0.85 HSD17B1 (0.74) KDM4EPOLBDHODHHSD17B1ALDH1A1
SCHEMBL27885546 0.85 SMN1; SMN2 (0.58) KDM4EPOLBALDH1A1HPGDCFD
SCHEMBL4603210 0.85 PTPN11 (0.62) KDM4EPOLBDHODHGPR35HCAR2
SCHEMBL7325594 0.84 DHODH (0.58) KDM4EPOLBDHODHALDH1A1HPGD
SCHEMBL5786865 0.83 KDM4E (0.64) KDM4EPOLBDHODHALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO claimed
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R KDM4E 2399/4885POLB 4403/4885DHODH 3439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.